Skip to main content

Table 2 KEGG pathway analysis of 38 overlapping genes in si-CSTF2 cell line

From: Genome-wide profiling reveals alternative polyadenylation of mRNA in human non-small cell lung cancer

UCSC ID Gene name KEGG_PATHWAY
uc001dlw.2 SH3-domain GRB2-like endophilin B1 hsa04144:Endocytosis
uc001kta.2 Beta-transducin repeat containing hsa04114:Oocyte meiosis, hsa04120:Ubiquitin mediated proteolysis, hsa04310:Wnt signaling pathway, hsa04340:Hedgehog signaling pathway
uc002pew.2 Calmodulin 3 (phosphorylase kinase, delta); calmodulin 2 (phosphorylase kinase, delta); calmodulin 1 (phosphorylase kinase, delta) hsa04020:Calcium signaling pathway, hsa04070:Phosphatidylinositol signaling system, hsa04114:Oocyte meiosis, hsa04270:Vascular smooth muscle contraction, hsa04720:Long-term potentiation, hsa04722:Neurotrophin signaling pathway, hsa04740:Olfactory transduction, hsa04910:Insulin signaling pathway, hsa04912:GnRH signaling pathway, hsa04916:Melanogenesis, hsa05010:Alzheimer’s disease, hsa05214:Glioma
uc003iev.1 Fibroblast growth factor 2 (basic) hsa04010:MAPK signaling pathway, hsa04810:Regulation of actin cytoskeleton, hsa05200:Pathways in cancer, hsa05218:Melanoma
uc002tbc.2 Mitogen-activated protein kinase kinase kinase kinase 4 hsa04010:MAPK signaling pathway
uc003hzp.2 Phospholipase A2, group XIIA hsa00564:Glycerophospholipid metabolism, hsa00565:Ether lipid metabolism, hsa00590:Arachidonic acid metabolism, hsa00591:Linoleic acid metabolism, hsa00592:alpha-Linolenic acid metabolism, hsa04010:MAPK signaling pathway, hsa04270:Vascular smooth muscle contraction, hsa04370:VEGF signaling pathway, hsa04664:Fc epsilon RI signaling pathway, hsa04730:Long-term depression, hsa04912:GnRH signaling pathway
uc003hbs.1 Phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase hsa00230:Purine metabolism
uc002fuw.3 Platelet-activating factor acetylhydrolase, isoform Ib, subunit 1 (45 kDa) hsa00565:Ether lipid metabolism
uc002jhg.2 Protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) hsa04210:Apoptosis, hsa04910:Insulin signaling pathway,
uc004czg.3 Pyruvate dehydrogenase (lipoamide) alpha 1 hsa00010:Glycolysis/Gluconeogenesis, hsa00020:Citrate cycle (TCA cycle), hsa00290:Valine, leucine and isoleucine biosynthesis, hsa00620:Pyruvate metabolism, hsa00650:Butanoate metabolism,
uc001xbo.2 Suppressor of cytokine signaling 4 hsa04630:Jak-STAT signaling pathway, hsa04910:Insulin signaling pathway, hsa04930:Type II diabetes mellitus